Skip to main content
SpringerLink
Log in

Uveal Melanoma: Diagnosis, Classification and Management

  • Chapter
  • First Online:
Intraocular Tumors

  • 540 Accesses

Abstract

Uveal melanoma (UM) is the most common primary intraocular malignancy in adults. It arises from melanocytes in the choroid, ciliary body and, less frequently, iris, and affects mainly light-skinned individuals in their sixth decade of life. Diagnosis of UM is often based on clinical examination, including slit lamp biomicroscopy, and ancillary studies, especially ultrasound. Biopsy is rarely required for diagnosis, but performed in selected cases for prognostication. In clinical practice, in addition to anatomical location, UM is routinely classified according to tumor dimensions, with large tumors (>8 mm in height) known to be associated with significantly higher chances for distant metastatic spread and death. Most UM cases are treated conservatively by means of plaque or proton beam radiotherapy, resulting with high tumor control rate, but also compromised vision due to late radiotherapy related complications.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Chang AE, Karnell LH, Menck HR. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer. 1998;83:1664–78.

    CAS  PubMed  Google Scholar 

  2. Hu D-N, Yu G-P, McCormick SA, Schneider S, Finger PT. Population-based incidence of uveal melanoma in various races and ethnic groups. Am J Ophthalmol. 2005;140:612.e1–8.

    Google Scholar 

  3. Singh AD, Turell ME, Topham AK. Uveal melanoma: trends in incidence, treatment, and survival. Ophthalmology. 2011;118:1881–5.

    PubMed  Google Scholar 

  4. Egan KM, Seddon JM, Glynn RJ, Gragoudas ES, Albert DM. Epidemiologic aspects of uveal melanoma. Surv Ophthalmol. 1988;32:239–51.

    CAS  PubMed  Google Scholar 

  5. Virgili G, et al. Incidence of uveal melanoma in Europe. Ophthalmology. 2007;114:2309–2315.e2.

    PubMed  Google Scholar 

  6. McLaughlin CC, et al. Incidence of noncutaneous melanomas in the U.S. Cancer. 2005;103:1000–7.

    PubMed  Google Scholar 

  7. Harbour JW, et al. Frequent mutation of BAP1 in metastasizing uveal melanomas. Science. 2010;330:1410–3.

    CAS  PubMed  PubMed Central  Google Scholar 

  8. Shields CL, et al. Association of ocular and oculodermal melanocytosis with the rate of uveal melanoma metastasis: analysis of 7872 consecutive eyes. JAMA Ophthalmol. 2013;131:993–1003.

    PubMed  Google Scholar 

  9. Gallagher RP, et al. Risk factors for ocular melanoma: Western Canada Melanoma Study. J Natl Cancer Inst. 1985;74:775–8.

    CAS  PubMed  Google Scholar 

  10. Chien JL, Sioufi K, Surakiatchanukul T, Shields JA, Shields CL. Choroidal nevus: a review of prevalence, features, genetics, risks, and outcomes. Curr Opin Ophthalmol. 2017;28:228–37.

    PubMed  Google Scholar 

  11. Singh AD, Kalyani P, Topham A. Estimating the risk of malignant transformation of a choroidal nevus. Ophthalmology. 2005;112:1784–9.

    PubMed  Google Scholar 

  12. Shields CL, et al. Choroidal nevus transformation into melanoma. Arch Ophthalmol. 2009;127:981.

    PubMed  Google Scholar 

  13. Damato EM, Damato BE. Detection and time to treatment of uveal melanoma in the United Kingdom: an evaluation of 2384 patients. Ophthalmology. 2012;119:1582–9.

    PubMed  Google Scholar 

  14. Finn AP, Materin MA, Mruthyunjaya P. Choroidal tumor biopsy. Retina. 2018;38:S79–87.

    PubMed  Google Scholar 

  15. Shields CL, et al. American joint committee on cancer classification of uveal melanoma (anatomic stage) predicts prognosis in 7731 patients. Ophthalmology. 2015;122:1180–6.

    PubMed  Google Scholar 

  16. Shields JA, Shields CL. Management of posterior uveal melanoma: past, present, and future: the 2014 Charles L. Schepens lecture. Ophthalmology. 2015;122:414–28.

    PubMed  Google Scholar 

  17. Fabian ID, et al. Primary photodynamic therapy with verteporfin for small pigmented posterior pole choroidal melanoma. Eye. 2017;31:519–28.

    CAS  PubMed  PubMed Central  Google Scholar 

  18. Accuracy of diagnosis of choroidal melanomas in the Collaborative Ocular Melanoma Study. COMS report no. 1. Arch Ophthalmol. 1990; 108:1268–1273.

    Google Scholar 

  19. Khan S. Clinical and pathologic characteristics of biopsy-proven iris melanoma. Arch Ophthalmol. 2012;130:57.

    PubMed  Google Scholar 

  20. Shields JA, Eagle RC, Ferguson K, Shields CL. Tumors of the nonpigmented epithelium of the ciliary body. Retina. 2015;35:957–65.

    PubMed  Google Scholar 

  21. Shields JA, Sanborn GE, Augsburger JJ. The differential diagnosis of malignant melanoma of the iris. A clinical study of 200 patients. Ophthalmology. 1983;90:716–20.

    CAS  PubMed  Google Scholar 

  22. Shields JA, Mashayekhi A, Ra S, Shields CL. Pseudomelanomas of the posterior uveal tract: the 2006 Taylor R. Smith Lecture. Retina. 2005;25:767–71.

    PubMed  Google Scholar 

  23. Bianciotto C, et al. Assessment of anterior segment tumors with ultrasound biomicroscopy versus anterior segment optical coherence tomography in 200 cases. Ophthalmology. 2011;118:1297–302.

    PubMed  Google Scholar 

  24. Shields CL, Kaliki S, Rojanaporn D, Ferenczy SR, Shields JA. Enhanced depth imaging optical coherence tomography of small choroidal melanoma: comparison with choroidal nevus. Arch Ophthalmol. 2012;130:850–6.

    PubMed  Google Scholar 

  25. Shields CL, et al. Chromosome 3 analysis of uveal melanoma using fine-needle aspiration biopsy at the time of plaque radiotherapy in 140 consecutive cases. Arch Ophthalmol. 2007;125:1017.

    PubMed  Google Scholar 

  26. Sagoo MS, et al. Plaque radiotherapy for juxtapapillary choroidal melanoma. JAMA Ophthalmol. 2014;132:697.

    PubMed  Google Scholar 

  27. Margo CE. The collaborative ocular melanoma study: an overview. Cancer Control. 2004;11:304–9.

    Google Scholar 

  28. McLean IW, Foster WD, Zimmerman LE, Martin DG. Inferred natural history of uveal melanoma. Invest Ophthalmol Vis Sci. 1980;19:760–70.

    Google Scholar 

  29. McLean IW, Foster WD, Zimmerman LE, Martin DG. Inferred natural history of uveal melanoma. Invest Ophthalmol Vis Sci. 1980;19:760–70.

    CAS  PubMed  Google Scholar 

  30. Shields CL, et al. Iris melanoma outcomes based on the American joint committee on cancer classification (eighth edition) in 432 patients. Ophthalmology. 2018;125:913–23.

    PubMed  Google Scholar 

  31. Zakka KA, Foos RY, Omphroy CA, Straatsma BR. Malignant melanoma. Analysis of an autopsy population. Ophthalmology. 1980;87:549–56.

    CAS  PubMed  Google Scholar 

  32. Kath R, et al. Prognosis and treatment of disseminated uveal melanoma. Cancer. 1993;72:2219–23.

    CAS  PubMed  Google Scholar 

  33. Zimmerman LE, McLean IW, Foster WD. Does enucleation of the eye containing a malignant melanoma prevent or accelerate the dissemination of tumour cells. Br J Ophthalmol. 1978;62:420–5.

    CAS  PubMed  PubMed Central  Google Scholar 

  34. Fabian ID, et al. Secondary enucleations for uveal melanoma: a 7-year retrospective analysis. Am J Ophthalmol. 2015;160:1104–1110.e1.

    PubMed  Google Scholar 

  35. Stallard HB. Radiotherapy for malignant melanoma of the choroid. Br J Ophthalmol. 1966;50:147–55.

    CAS  PubMed  PubMed Central  Google Scholar 

  36. Collaborative Ocular Melanoma Study Group. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: V. Twelve-year mortality rates and prognostic factors: COMS report No. 28. Arch Ophthalmol. 2006;124:1684–93.

    Google Scholar 

  37. Gündüz K, Shields CL, Shields JA, Cater J, Brady L. Plaque radiotherapy for management of ciliary body and choroidal melanoma with extraocular extension. Am J Ophthalmol. 2000;130:97–102.

    PubMed  Google Scholar 

  38. Shields CL, et al. Iris melanoma management with iodine-125 plaque radiotherapy in 144 patients: impact of melanoma-related glaucoma on outcomes. Ophthalmology. 2013;120:55–61.

    PubMed  Google Scholar 

  39. Sagoo MS, et al. Plaque radiotherapy for juxtapapillary choroidal melanoma overhanging the optic disc in 141 consecutive patients. Arch Ophthalmol. 2008;126:1515–22.

    PubMed  Google Scholar 

  40. Agraval U, et al. Use of ruthenium-106 brachytherapy for iris melanoma: the Scottish experience. Br J Ophthalmol. 2018;102:74–8.

    PubMed  Google Scholar 

  41. Fernandes BF, et al. Management of iris melanomas with 125Iodine plaque radiotherapy. Am J Ophthalmol. 2010;149:70–76.e2.

    PubMed  Google Scholar 

  42. Sagoo MS, et al. Plaque radiotherapy for juxtapapillary choroidal melanoma. Ophthalmology. 2011;118:402–7.

    PubMed  Google Scholar 

  43. Krema H, et al. Management of ciliary body melanoma with iodine-125 plaque brachytherapy. Can J Ophthalmol. 2009;44:395–400.

    PubMed  Google Scholar 

  44. Gragoudas ES, et al. Proton beam irradiation. An alternative to enucleation for intraocular melanomas. Ophthalmology. 1980;87:571–81.

    CAS  PubMed  Google Scholar 

  45. Zografos L, et al. Rapport sur le traitement conservateur des mélanomes de l’uvée a la clinique ophtalmologique universitaire de Lausanne∗. Klin Monatsbl Augenheilkd. 1988;192:572–8.

    CAS  PubMed  Google Scholar 

  46. Dendale R, et al. Proton beam radiotherapy for uveal melanoma: results of Curie Institut–Orsay Proton Therapy Center (ICPO). Int J Radiat Oncol. 2006;65:780–7.

    Google Scholar 

  47. Damato B, Kacperek A, Chopra M, Campbell IR, Errington RD. Proton beam radiotherapy of choroidal melanoma: the Liverpool-Clatterbridge experience. Int J Radiat Oncol Biol Phys. 2005;62:1405–11.

    PubMed  Google Scholar 

  48. Papakostas TD, Lane AM, Morrison M, Gragoudas ES, Kim IK. Long-term outcomes after proton beam irradiation in patients with large choroidal melanomas. JAMA Ophthalmol. 2017;135:1191.

    PubMed  PubMed Central  Google Scholar 

  49. Shah SU, et al. Intravitreal bevacizumab at 4-month intervals for prevention of macular edema after plaque radiotherapy of uveal melanoma. Ophthalmology. 2014;121:269–75.

    PubMed  Google Scholar 

  50. Shields JA, Glazer LC, Mieler WF, Shields CL, Gottlieb MS. Comparison of xenon arc and argon laser photocoagulation in the treatment of choroidal melanomas. Am J Ophthalmol. 1990;109:647–55.

    CAS  PubMed  Google Scholar 

  51. Meyer-Schwickerath G, Vogel M. Treatment of malignant melanomas of the choroid by photocoagulation. Trans Ophthalmol Soc U K. 1977;97:416–20.

    CAS  PubMed  Google Scholar 

  52. Oosterhuis JA, Journée-de Korver HG, Kakebeeke-Kemme HM, Bleeker JC. Transpupillary thermotherapy in choroidal melanomas. Arch Ophthalmol. 1995;113:315–21.

    CAS  PubMed  Google Scholar 

  53. Singh AD, Kivelä T, Seregard S, Robertson D, Bena JF. Primary transpupillary thermotherapy of ‘small’; choroidal melanoma: is it safe? Br J Ophthalmol. 2008;92:727–8.

    PubMed  Google Scholar 

  54. Jmor F, Hussain RN, Damato BE, Heimann H. Photodynamic therapy as initial treatment for small choroidal melanomas. Photodiagn Photodyn Ther. 2017;20:175–81.

    CAS  Google Scholar 

  55. Rundle P. Treatment of posterior uveal melanoma with multi-dose photodynamic therapy. Br J Ophthalmol. 2014;98:494–7.

    PubMed  Google Scholar 

  56. Fabian ID, et al. Primary photodynamic therapy with verteporfin for pigmented posterior pole cT1a choroidal melanoma: a 3-year retrospective analysis. Br J Ophthalmol. 2018;102(12):1705–10. https://doi.org/10.1136/bjophthalmol-2017-311747.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Ocular Oncology Service, Goldschleger Eye Institute, Sheba Medical Center, Tel-Aviv University, Tel Aviv, Israel

    Ronel Veksler & Ido Didi Fabian

Authors
  1. Ronel Veksler
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ido Didi Fabian
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ido Didi Fabian .

Editor information

Editors and Affiliations

  1. Sankara Nethralaya, Chennai, Tamil Nadu, India

    Vikas Khetan

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Veksler, R., Fabian, I.D. (2020). Uveal Melanoma: Diagnosis, Classification and Management. In: Khetan, V. (eds) Intraocular Tumors. Springer, Singapore. https://doi.org/10.1007/978-981-15-0395-5_6

Download citation

  • DOI: https://doi.org/10.1007/978-981-15-0395-5_6

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-15-0394-8

  • Online ISBN: 978-981-15-0395-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation